Latest Financials News

Auckland Airport posted a 3% revenue increase and a stable underlying profit of NZD 309 million in FY26, driven by robust passenger growth and a $1 billion infrastructure push, while cautioning on near-term fuel price volatility and geopolitical risks.

Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.

H2G Limited trims its half-year loss by a third while advancing sodium-ion battery production and securing a $4.5 million sales pipeline. Strategic partnerships and government certification efforts aim to boost market adoption.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

InvestSMART Group Limited swung to a net loss of $575,633 in FY26, marking a sharp reversal from the prior year’s profit, amid a strategic pivot including a pending $16 million sale of its Intelligent Investor business.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.

Synertec Corporation has been awarded the delivery phase of the Brooklyn Pump Station IO Upgrade by Melbourne Water, extending a contract valued at approximately $1.1 million. The project modernises critical water infrastructure with advanced operational technology.

MA Credit Income Trust (ASX: MA1) launches a voluntary off-market buy-back for up to 2.5% of units at net asset value, aiming to provide liquidity and capital management benefits to unitholders.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

Seeka Ltd (NZX:SEK) has announced a fully imputed dividend of 20 cents per share, payable in October, alongside a reinstatement of its biannual dividend schedule. The dividend reinvestment plan offers a 2% discount on shares acquired via the plan.